NRX Pharmaceuticals Inc
NRXP
Get informed when a big investor buys or sells
+ FollowMarket Cap$61.54M
Close$
$0.58
83.3% downside
Current Fair Value
83.3% downsideOvervalued by 83.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $61.54 Million |
|---|---|
| Enterprise Value | $35.69 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.34 |
| Beta | 2.18 |
| Outstanding Shares | 37,649,382 |
Return
| Return on Equity | 13811.76% |
|---|---|
| Return on Assets | -68.74% |
| Return on Invested Capital | -7598.25% |
Valuation & Multiples
| P/E Ratio | -4.79 |
|---|---|
| PEG | 79.4 |
| Price to Sales | - |
| Price to Book Ratio | -3.44 |
| Enterprise Value to Revenue | 10.51 |
| Enterprise Value to EBIT | -1.64 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | -4.91 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 17, 2026
EPS Estimate
$-0.11
Average shareholder expectationRevenue Estimate
$1.33 M
Average shareholder expectationNext Earnings Call
Expected Date
November 13, 2026
EPS Estimate
$-0.07
Average shareholder expectationRevenue Estimate
$1.54 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.0068▲ 100.68% |
|---|---|
| Total Calls | 131,500▲ 39.60% |
| Total Puts | 132,400▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 19.20%▲ 2.70% |
|---|---|
| Total Invested | $13.25M▼ 6.52% |
| Investors Holding | 38▲ 7.00% |
ESG Score
No data
About NRX Pharmaceuticals Inc
2 employeesBig Rock Partners is a blank check company formed for the purpose of entering into a merger, stock exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more busi...